CCRN
CROSS COUNTRY HEALTHCARE INCPrice
Daily candles with volume.
Signal stack
Where each data set points today.
- InsidersBEARISH
1 insider sold $60.1K.
- InstitutionsMIXED
Q2 2026: 20 added (2 new), 17 trimmed or exited. Largest new: Fil $17.1M, Millennium Management $12.1M.
- EstimatesFALLING
Current-quarter EPS estimate $0.021 → $0.017 over 90 days. 1 up, 1 down in 30 days.
- Short sellersSTEADY
Short interest −5.4% to 824.4K shares. 1.7 days to cover, ≈2.5% of shares.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| FIL Ltd | NEW | $17.1M |
| MILLENNIUM MANAGEMENT LLC | NEW | $12.1M |
| GABELLI FUNDS LLC | DOUBLED | $11.5M |
| First Eagle Investment Management, LLC | ADD | $9.9M |
| Russell Investments Group, Ltd. | TRIM | $4.8M |
| Walleye Capital LLC | TRIM | $4.4M |
| Allianz Asset Management GmbH | ADD | $4.4M |
| Qube Research & Technologies Ltd | ADD | $3.3M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
last action Jun 2026| Date | Firm | Rating |
|---|---|---|
| Jun 8, 2026 | Barrington Research MAINTAIN | Market Perform |
| May 11, 2026 | Truist Securities MAINTAIN | Hold |
| May 8, 2026 | Benchmark DOWNGRADE | Hold |
| May 7, 2026 | Wedbush DOWNGRADE | Neutral |
| Mar 19, 2026 | Wedbush UPGRADE | Outperform |
| Mar 5, 2026 | Benchmark UPGRADE | Buy |
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Jul 21, 2026 | FITZGERALD GALE S Director | TO ISSUER | $1.5M |
| Jul 21, 2026 | FITZGERALD GALE S Director | TO ISSUER | $1.1M |
| Jul 21, 2026 | CASH W LARRY Director | TO ISSUER | $3.0M |
| Jul 21, 2026 | Allen Dwayne Director | TO ISSUER | $414.6K |
| Jul 21, 2026 | Nevin Janice Elizabeth Director | TO ISSUER | $644.2K |
| Jul 21, 2026 | Bhamidipati Venkat Director | TO ISSUER | $394.3K |
| Jul 21, 2026 | Clark Kevin Cronin Chief Executive Officer | TO ISSUER | $3.3M |
| Jul 21, 2026 | Hawkins Amiee Lin Chief Operating Officer | TO ISSUER | $369.6K |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current FY | $0.11 | $0.09–$0.15 | +14.0% | $989.0M |
| Next Q | $0.04 | $0.03–$0.06 | +5.0% | $249.7M |
| Next FY | $0.29 | $0.24–$0.35 | +4.2% | $1.0B |
| Current Q | $0.02 | $0.00–$0.03 | +6.1% | $242.6M |
Short side
FINRA· Jul 15, 2026| Jul 20, 2026 | Deletion | Resumed |
SecBot reports
10 filings · 5 bullish · 1 bearish · 1 mixed · 3 neutral- NEUTRAL 425Jul 6, 2026
Cross Country Healthcare filed supplemental disclosures to its merger proxy statement in response…
The special meeting is July 16, 2026 — 10 days away. The supplemental disclosures are a standard response to merger litigation and do not change deal economics. The two shareholder lawsuits seek to…
- NEUTRAL 8-KJul 6, 2026
Cross Country Healthcare filed an 8-K to voluntarily supplement its proxy statement with…
The merger is on track for shareholder vote on July 16. The stock should trade near the deal price. Monitor for any further litigation or vote results. No trading opportunity unless the deal breaks.
- BULLISH DEFM14AJun 15, 2026
Cross Country Healthcare (CCRN) has filed a definitive merger proxy (DEFM14A) for its acquisition…
The stock is trading at a narrow ~$0.08 discount to the $13.25 offer, reflecting high probability of completion. Monitor the HSR waiting period expiration on June 22 and the stockholder vote on July…
- BULLISH PREM14AJun 3, 2026
Cross Country Healthcare (CCRN) filed a preliminary proxy statement (PREM14A) seeking shareholder…
CCRN stock should trade close to the $13.25 deal price with a slight discount reflecting execution risk (shareholder vote, HSR clearance). The HSR waiting period expires June 22, 2026; any second…
All CCRN filing & press-release reports (10)
- 8-K reportJul 6, 2026
- 425 reportJul 6, 2026
- DEFM14A reportJun 15, 2026
- PREM14A reportJun 3, 2026
- DEFA14A reportMay 7, 2026
- DEFA14A reportMay 7, 2026
- 8-K reportMay 7, 2026
- 8-K reportMay 7, 2026
- 8-K reportApr 17, 2026
- 8-K reportMar 4, 2026